Enasidenib's innovative therapy offers a new treatment option for AML patients who are unresponsive to or experience relapse with conventional therapies.
Authentic
Guarantee
Fast Delivery
Privacy Encilidipine, also known as IDHIFA or encilidipine mesylate, is a drug used to treat adult patients with relapsed or refractory acute myeloid leukemia···【Read More】
Update: 12 Mar,2026Source: Haiou HealthViews: 71
Enshidipine, an innovative drug targeting isocitrate dehydrogenase-2 (IDH2) mutations, is indicated for adult patients with relapsed or refractory acu···【Read More】
Update: 12 Mar,2026Source: Haiou HealthViews: 72
Copyright2024@ BIGBEAR All right reserved BIGBEAR



